Atrás
Rango del Día
$3.00
$3.00
Rango de 52 Semanas
$1.97
$4.23
Volumen
1,000
Promedio 50D / 200D
$3.00
/
$2.99
Cierre Anterior
$3.00
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -5.1 | 0.4 |
| P/B | 0.7 | 2.9 |
| ROE % | -14.3 | 3.7 |
| Net Margin % | -35.0 | 3.9 |
| Rev Growth 5Y % | -11.8 | 10.0 |
| D/E | 0.7 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2028 |
-$0.12
-$0.13 – -$0.12
|
5.2 B | 1 |
| FY2027 |
-$0.22
-$0.23 – -$0.21
|
4.1 B | 1 |
| FY2026 |
-$0.52
-$0.54 – -$0.50
|
3.3 B | 1 |
Puntos Clave
Revenue declined -11.82% annually over 5 years
Negative free cash flow of -1.21B
PEG of 0.72 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 36.75%
Capital intensive — 30.75% of revenue goes to capex
Crecimiento
Revenue Growth (5Y)
-11.82%
Revenue (1Y)24.93%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-14.30%
ROIC-6.70%
Net Margin-35.00%
Op. Margin-37.37%
Seguridad
Debt / Equity
0.69
Current Ratio1.60
Interest Coverage-12.37
Valoración
P/E Ratio
-5.09
P/B Ratio0.72
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 24.93% | Revenue Growth (3Y) | 27.27% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -11.82% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2.43B | Net Income (TTM) | -851.83M |
| ROE | -14.30% | ROA | -6.88% |
| Gross Margin | 72.34% | Operating Margin | -37.37% |
| Net Margin | -35.00% | Free Cash Flow (TTM) | -1.21B |
| ROIC | -6.70% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.69 | Current Ratio | 1.60 |
| Interest Coverage | -12.37 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -5.09 | P/B Ratio | 0.72 |
| P/S Ratio | 1.78 | PEG Ratio | 0.72 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 4.34B | Enterprise Value | 5.86B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.43B | 1.95B | 1.50B | 1.45B | 4.02B |
| Net Income | -851.83M | -1.28B | -2.28B | -2.39B | -718.56M |
| EPS (Diluted) | -0.84 | -1.30 | -2.32 | -2.60 | -0.81 |
| Gross Profit | 1.76B | 1.45B | 835.26M | 927.21M | 2.77B |
| Operating Income | -909.47M | -1.30B | -2.45B | -2.75B | -592.71M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 12.39B | 10.80B | 11.36B | 12.56B | 11.05B |
| Total Liabilities | 6.16B | 4.85B | 4.02B | 2.78B | 2.72B |
| Shareholders' Equity | 6.03B | 5.88B | 7.17B | 9.48B | 7.96B |
| Total Debt | 4.14B | 2.93B | 1.79B | 1.32B | 628.20M |
| Cash & Equivalents | 2.62B | 2.49B | 3.78B | 6.00B | 3.50B |
| Current Assets | 4.46B | 4.28B | 5.55B | 7.22B | 5.83B |
| Current Liabilities | 2.78B | 2.53B | 2.48B | 1.77B | 2.02B |